Oxford Nanopore Technologies
plc
Oxford
Nanopore to Present at 43rd Annual J.P. Morgan Healthcare
Conference
7 January 2025
Oxford Nanopore Technologies plc
(LSE: ONT) ("Oxford Nanopore"), the company delivering a new
generation of nanopore-based molecular sensing technology, will
participate in the 43rd Annual J.P. Morgan Healthcare Conference at
the Westin St. Francis Hotel, San Francisco, California,
USA.
Gordon Sanghera, Chief Executive
Officer, will present on Monday, 13 January 2025 at 11:15 - 11:55am
PST / 7:15 - 7:55pm GMT. The 40-minute session will include a
presentation and a moderated Q&A discussion.
A live
webcast of the presentation and
Q&A session can be accessed via the Investor Relations section
of Oxford Nanopore's website at: https://nanoporetech.com/about-us/investors/reports.
A replay will be available for at least 30 days following the event
via the same link.
[ENDS]
For further information, please
contact:
Oxford Nanopore Technologies plc
Investors:
ir@nanoporetech.com
Media:
media@nanoporetech.com
Teneo (communications adviser to the
Company)
Tom Murray, Jo Blackshaw
+44 (0) 20 7353 4200
OxfordNanoporeTechnologies@teneo.com
About Oxford Nanopore Technologies plc:
Oxford Nanopore Technologies' goal
is to bring the widest benefits to society through enabling the
analysis of anything, by anyone, anywhere. The Group has developed
a new generation of nanopore-based sensing technology that is
currently used for real-time, high-performance, accessible, and
scalable analysis of DNA and RNA. The technology is used in more
than 125 countries, to understand the biology of humans, plants,
animals, bacteria, viruses and environments as well as to
understand diseases such as cancer. Oxford Nanopore's
technology also has the potential to provide broad, high impact,
rapid insights in a number of areas including healthcare, food and
agriculture.
For more information please
visit: www.nanoporetech.com